OBIO CIK: 1814114

Orchestra BioMed Holdings, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
3.32
FY23:
2.57
FY24:
2.43
FY25:
33.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−0.39
FY22:
−32.7
FY23:
−51.5
FY24:
−64.3
FY25:
−51.8
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−31.4
FY23:
−49.8
FY24:
−63.9
FY25:
−51.5
(positive)
Change from FY22 to FY25
millions USD
FY21:
–
FY22:
−33.6
FY23:
−49.1
FY24:
−61.0
FY25:
−52.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−0.38
FY22:
−33.6
FY23:
−49.1
FY24:
−61.0
FY25:
−52.7

All amounts in millions USD Data sources:SEC EDGARTwelve Data